Prostate Cancer - Results from #2740

Redefining 18F DCFPyl PSMA-PET detected local recurrence from radical prostatectomy histopathology. May 24, 2023

68Ga-PSMA PET/CT evaluation in men enrolled in prostate cancer Active Surveillance. May 24, 2023

Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer. May 24, 2023

Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. May 23, 2023

Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over time. May 23, 2023

Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort stu May 23, 2023

Test-retest repeatability of organ uptake on PSMA-targeted 18 F-DCFPyL PET/CT in patients with prostate cancer. May 23, 2023

18 F-sodium fluoride positron emission tomography quantitation of bone metastases in African American and non-African American men with metastatic prostate cancer. May 23, 2023

Management of Prostate Cancer in Older Adults. May 22, 2023

Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectious complications. May 22, 2023

Guidelines for genetic testing in prostate cancer: a scoping review. May 22, 2023

Predictive value of kallikrein forms and β-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy. May 22, 2023

Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer. May 22, 2023

Effects of In-office Dispensing by Single-specialty Urology Practices on Management of Advanced Prostate Cancer. May 22, 2023

Methylation status of various gene loci in localized prostate cancer: Novel biomarkers for diagnostics and biochemical recurrence. May 19, 2023

Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)-A Potential New Standard of Care. May 19, 2023

Diagnostic Impact of Dual-Time PET/CT with 68Gallium-PSMA in Prostate Cancer and 68Gallium-DOTATOC in Neuroendocrine Tumors. May 19, 2023

Real-World Treatment Patterns Among French Patients With Metastatic Castration-Resistant Prostate Cancer Under Abiraterone or Enzalutamide. May 19, 2023

A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer Patients. May 19, 2023

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis. May 18, 2023

Page 138 of 1439